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ABSTRACT 
The novel 2-thioxo-benzo[5,6]chromeno[2,3-d]pyrimidin-4-one derivatives were prepared by one pot multicomponent 
condensation reaction involving thiobarbituric acids, aromatic aldehydes and β-napthol in acetonitrile-water as solvent 
using surfactant, cetylpyridinium chloride (CPC) at water bath temperature in good yields. The structures of the 
compounds were confirmed by elemental analyses and spectral data. 
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1.INTRODUCTION  
Multi-component, one-pot syntheses have received considerable attention because of their wide range of applications in 
pharmaceutical chemistry for generation of structural diversity and combinatorial libraries for drug discovery.[1] The use of 
multicomponent reaction (MCRs) increases due to its flexible, atom economic in nature, operational simplicity and proceed 
through a sequence of reaction equilibria, yielding the target product.[2]
 
MCRs have also been found to use in 
synthesizing structurally diverse bioactive heterocyclic compounds.[3] The use of water reduces the harmful organic 
solvents and is regarded as the greener method in Chemistry.[4]
 
Nitrogen-containing heterocycles are of broad 
pharmaceutical interest which justifies the continuing efforts in the development of new synthetic strategies.[5]
 
Chromene derivatives represent an important class of compounds in many natural products [6] and have been reported to 
possess various pharmacological activities such as antimicrobial,[7] antitumor,[8] antiaggregating,[9] antidepressant[10] 
and antiproliferative activities.[11] Among the nitrogen containing heterocycles, the chromeno-pyrimidine derivatives are 
known to possess antiallergic,[12]antimicrobial,[13]
 
antioxidant,[14]
 
anti-inflammatory[15] and anticancer activities.[16] In 
the field of medicinal chemistry, functionally substituted chromene have been found to play an increasing role in 
approaching synthetic promising compounds.[17] 
 
As surfactant, at an ambient condition in an aqueous media, aggregates to form micelles with hydrophobic tail and 
hydrophilic head, micellar surfactants as catalysts are widespread[18] and found to be used in different reactions as a 
route for synthesis in aqueous solutions.[19] The studies of surfactant-promoted reactions have been increasing, such as, 
reaction of 1,4-quinone with oxygen nucleophiles in aqeous micelles,[20] surfactant  assisted organic reactions in 
water,[21] Pictet-Spengler reactions.[22] 
In view of the above biological activities, various synthetic methods have been reported for the preparation of chromeno-
pyrimidinones derivatives. In continuation of our work on the synthesis of fused heterocyclic compounds derived from 
thiobarbituric acids,[23]syntheses of 12-aryl-2-thioxo-dihydro-1H-benzo[6,7]chromeno-[3,2-d]pyrimidine-4(12H)-ones in 
good yields were taken up. Herein, we are reporting the synthesis of the novel chromeno[3,2-d]pyrimidinones derivatives 
(2) in one-pot, multicomponent reaction using the surfactant cetylpyridinium chloride (CPC) (Scheme 1). The reactions 
occur via a three component, one pot reaction between thiobarbituric acid, aldehydes (1) and β-napthol using CPC in 
acetonitrile:water (1:1) as solvent, heating at water bath temperature. Addition of the surface active agents in aqueous 
organic solvent has been known and the use of the surfactant as catalyst has been studied for various organic reactions. 
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2. General procedure for synthesis of compound (2a). In a typical experiment, p-nitrobenzaldehyde 
(1.0 mmol), β-napthol (1.0 mmol), thiobarbituric acid (1.0 mmol) and CPC (0.015 mmol %) were taken in a round bottom 
flask using water and acetonitrile as solvent in 1:1 ratio. The reaction mixture was refluxed for 8 hours in water bath 
temperature. The reaction was monitored by TLC. After the completion of reaction, the solid was separated and washed 
with water several times to remove the surfactant and washed again with acetonitrile to remove all the starting substrate to 
give the pure product, 2a (85%). 
 
5-(4-nitrophenyl)-2-thioxo-2,3-dihydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(5H)-one (2a). Yellow solid; m.p. 
207-210
0
C; IR (KBr): νmax 3541, 1651, 1537, 1445, 1350, 1198, 1132, 1015, 849 cm
-1
; 
1
H NMR (DMSO-d6, 300 MHz): ∂ 
5.70 (s, 1H), 6.72 (m, 1H, ArH), 6.85 (m, 1H, ArH), 7.01 (d, 2H, J=7.6 Hz, ArH), 7.24 (m, 4H, ArH), 7.67 (d, 2H, J=7.6 Hz, 
ArH), 10.90 (br s, 1H, NH), 11.20 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂ 173.57, 152.88, 145.70, 128.26, 123.52, 
95.62, 31.63; ; HRMS (EI) cald for C25H23N3O4S: 461.53; found 461.104. 
5-(4-chlorophenyl)-2-thioxo-2,3-dihydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(5H)-one(2b): White solid; m.p: 
198-203
0
C; IR (KBr): νmax 3524, 1660, 1537, 1443, 1359, 1201, 1134, 1013, 866 cm
-1
; 
1
H NMR (DMSO-d6, 300 MHz): ∂ 
5.80 (s, 1H), 6.97-7.22 (m, 10H, ArH), 11.32 (br s, 1H, NH), 11.69 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂173.37, 
164.01, 163.03, 142.73, 129.78, 128.93, 128.01, 95.98, 30.60; HRMS (EI) cald for C21H13ClN2O2S : 393.0464; found 
393.0478. 
5-(1H-indol-3-yl)-2-thioxo-2,3-dihydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(5H)-one(2c): Orange solid; m.p: 
188-192
0
C; IR (KBr): νmax 3538, 1655, 1528, 1377, 1277, 1213, 1157 cm
-1
; 
1
H NMR (DMSO-d6, 300 MHz): ∂ 5.80 (s, 1H), 
6.97-7.22 (m, 10H, ArH), 12.28 (br s, 1H, NH), 12.32 (br s, 1H, NH), 13.01 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂ 
178.19, 163.26, 161.46, 145.05, 141.54, 137.11129.54, 124.53, 123.59, 118.35, 113.86, 112.88, 109.23, 29.50; HRMS 
(EI) cald for C21H13ClN2O2S : 304.3127; found 304.3238.  
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5-(3-hydroxynaphthalen-1-yl)-2-thioxo-2,3,4a,5-tetrahydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(12aH)-
one(2d): Reddish Orange solid; m.p: 195-198
0
C; IR (KBr): νmax 3452, 3032, 1678, 1564, 1458, 1211, 1138, 814 cm
-1
; 
1
H 
NMR (DMSO-d6, 300 MHz): ∂ 5.56 (s, 1H), 7.15 (m, 2H, ArH), 7.22 (m, 2H, ArH), 7.55 (m, 2H, ArH), 7.60 (m, 2H, ArH), 
7.88 (m, 2H, ArH), 8.22 (m, 2H, ArH), 11.55 (br s, 1H, NH), 12.20 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂ 174.88, 
173.46, 160.25, 156.78, 148.25, 131.42, 129.80, 128.04, 126.61, 126.49, 123.14, 119.11, 109.14, 43.16, 29.56; HRMS 
(EI) cald for C25H18N2O3S : 426.1038; found 426.4870. 
5-(4-dimethylaminophenyl)-2-thioxo-2,3-dihydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(5H)-one(2e): Redish 
orange solid; m.p: 205-208
0
C; IR (KBr): νmax 3457, 3119, 1634, 1537, 1495, 1373, 1194, 1142, 1011 cm
-1
; 
1
H NMR 
(DMSO-d6, 300 MHz): ∂ 3.00 (s, 3H, , NCH3), 3.02 (s, 3H, , NCH3), 5.90 (s, 1H), 6.75 (m, 2H, ArH), 7.22 (m, 2H, ArH), 
7.40 (m, 2H, ArH), 8.22 (m, 2H, ArH), 8.48 (m, 2H, ArH), 11.98 (br s, 1H, NH), 12.05 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 
75 MHz): ∂ 178.02, 173.46, 163.54, 160.98, 156.66, 155.26, 140.25, 128.62, 120.92, 112.01, 109.83, 95.92, 46.09, 30.86; 
HRMS (EI) cald for C23H19N3O2S : 401.1198; found 401.4809. 
5-(4-carbaldehydophenyl)-2-thioxo-2,3-dihydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(5H)-one(2f): Orange 
solid; m.p: 201-203
0
C; IR (KBr): νmax 3522, 3148, 1670, 1574, 1518, 1433, 1298, 1207, 1148 cm
-1
; 
1
H NMR (DMSO-d6, 
300 MHz): ∂ 4.50 (s, 1H), 5.90 (s, 1H), 7.12-8.25 (m, 10H, ArH), 11.62 (br s, 1H, CHO), 12.25 (br s, 1H, NH), 12.42 (br s, 
1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂ 178.42, 173.50, 162.53, 145.23, 132.70, 128.60, 61.30, 29.56; HRMS (EI) cald 
for C22H14N2O3S : 386.4232; found 386.0725. 
5-Propyl-2-thioxo-2,3-dihydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(5H)-one(2g): Blacksolid; m.p: 188-192
0
C; IR 
(KBr): νmax 3178, 1686, 1582, 1522, 1316, 1165 cm
-1
; 
1
H NMR (DMSO-d6, 300 MHz): ∂ 0.82 (m, 3H, CH3), 1.18 (m, 2H, 
CH2), 2.28 (m, 2H, CH2), 5.78 (m, 1H), 7.12 (m, 2H, ArH), 7.32-7.45 (m, 2H, ArH), 7.65-7.72 (m, 2H, ArH), 11.98 (br s, 1H, 
NH), 12.05 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂ 178.22, 157.26, 145.48, 135.25129.79, 128.60, 128.04, 
126.60, 126.48, 123.13, 119.10, 109.13, 31.81, 29.56, 22.43, 14.48; HRMS (EI) cald for C18H16N3O2S : 324.0932; found 
324.3968. 
5-(2,4-dimethoxyphenyl)-2-thioxo-2,3,4a,5-tetrahydro-1H-benzo[6,7]chromeno[2,3-d]pyrimidin-4(12aH)-one(2h): 
White solid; m.p: 185-187
0
C; IR (KBr): νmax 3181, 1688, 1576, 1543, 1495, 1379, 1260, 1175, 1034, 949 cm
-1
; 
1
H NMR 
(DMSO-d6, 300 MHz): ∂ 3.73 (s, 3H, OCH3), 3.85 (s, 3H, , OCH3), 4.56 (s, 1H), 7.08-7.23 (m, 5H, ArH), 7.40-8.13 (m, 4H, 
ArH), 12.34 (br s, 1H, NH), 12.48 (br s, 1H, NH);
 13
C NMR (DMSO-d6, 75 MHz): ∂ 178.49, 161.73, 159.44, 155.17, 154.09, 
150.11, 145.35, 129.24, 127.99, 126.06, 125.90, 122.59, 121.59, 121.17, 118.39, 116.98, 56.25, 55.46, 28.84; HRMS (EI) 
cald for C23H20N2O4S : 420.4809; found 420.1144. 
3. Results and discussion 
For optimization of reaction condition, various surfactants such as sodium dodecylsulphate (SDS), 
cetyltrimethylammonium bromide (CTAB), cetylpyridinium chloride (CPC), tetradecyltrimethyl ammonium bromide (TTAB), 
TEAB were employed as catalyst in water alone and in water:acetonitrile (1:1) as solvent for the reaction of thiobarbituric 
acid, p-nitrobenzaldehyde and β-napthol (table 1). No expected product was observed when SDS (1 mmol) was used in 
water (entry 1). When SDS (1 mmol) was employed as catalyst in water:acetonitrile (1:1) solvent, the product 2a was 
afforded in 42% yield on refluxing at water bath temperature (entry 4); however, expected product was not obtained on 
stirring at room temperature (entry 2) and at higher temperatures (entry 3). While TTAB, TEAB and CTAB afforded around 
60-65% overall yield (entries 5, 6 & 8); CPC (1 mmol) gave 85% yield (entry 7). On taking CPC (1.5 mmol) as catalyst in 
water:acetonitrile (1:1) ass solvent, 2a was obtained as 82% yield (entry 9), and reaction in water afforded 53% yield using 
CPC (1.0 mmol) as catalyst by refluxing for 24 hr (entry 10). The influence of the solvent system was further evaluated and 
the usage of a medium-polarity solvent acetonitrile which is miscible with water is used in various ratios with water as 
solvent. It can be seen that the use of the mixture of acetonitrile in water can enhance the solubility of the substrate and 
increases the yield of the product 2a.
16 
Thus, from the above observation, it was found that treatment of thiobarbituric acid, 
p-nitrobenzaldehyde and β-napthol using CPC as catalyst in water:acetonitrile (1:1) on refluxing at water bath temperature 
afforded the desired product, 2a significantly (85%). 
 
Fig.1. Schematic diagram illustrating the role of CPC 
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Table 1: Optimization of reaction condition 
 
Entry Surfactant Solvent Temperature Time (hr) 2a (%) 
1 SDS (1mmol) H2O R.T - - 
2 SDS (1mmol) CH3CN: H2O R.T - - 
3 SDS (1mmol) CH3CN: H2O 80
o
C - - 
4 SDS (1mmol) CH3CN: H2O Reflux 24 42 
5 TTAB (1mmol) CH3CN: H2O Reflux 18 60 
6 CTAB (1mmol) CH3CN: H2O Reflux 20 65 
7 CPC (1mmol) CH3CN: H2O Reflux 12 85 
8 TEAB (1mmol) CH3CN: H2O Reflux 14 65 
9 CPC (1.5mmol) CH3CN: H2O Reflux 12 82 
10 CPC (1mmol) H2O Reflux 24 53 
 
From the observation of the optimization studies, the multi-component reaction (MCR) of this greener system was further 
studied to a variety of thiobarbituric acid and aldehydes (1) with β-napthol using CPC as catalyst in water:acetonitrile (1:1) 
on refluxing at water bath temperature to yield 2 (table 2). The formation of 2 is assumed to proceed through the in situ 
intramolecular cyclization of the intermediate [A] which is formed by nucleophilic addition of β-napthol to the condensation 
product of thiobarbituric acid and aldehyde (scheme 2). We have observed that the reaction was more favourable with the 
electron withdrawing group and less facile with the electron releasing group. 
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Table 2: Reaction of thiobarbituric acid with aldehydes (1) to give the products, 2. 
 
Entry                Aldehyde (1)                  Product (2)                  Time (hr)        Yield (%)        m.p (
o
C) 
 
1                                                       8                            85       207-210 
2                                                  10                          80        198-203 
3                                             4                             93        188-192 
4                                         3                               85               195 
5                                                   4                             85          205-208 
6                                                    4                             92         201-203 
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7                                               5               75         188-192 
8                                                             4             80            
 
Conclusion 
In conclusion, an efficient way of synthesising substituited chromeno pyrimidine derivatives in good yields was developed. 
A series of chromeno pyrimidine derivatives which were able to synthesise from this greener one pot multi component 
reaction of thiobarbituric acid, aromatic aldehydes, β-napthol using surfactant and acetonitrile:water as solvent has been 
described. The reaction products were characterised by IR, 
1
H NMR, 
13
C NMR & Mass spectral data. 
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